MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Friedreich Ataxia

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 126
  • Start Date: November 17, 2020
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)
Clinical Trial
Other
  • Status: Not yet recruiting
  • Study Type: Other
  • Participants: 300
  • Start Date: October 1, 2020
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals With Friedreich Ataxia (TRACK-FA)
Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 50
  • Start Date: September 23, 2020
Home Based Tele-exercise for People With Chronic Neurological Impairments
Clinical Trial
Dietary Supplement
  • Status: Recruiting
  • Study Type: Dietary Supplement
  • Participants: 72
  • Start Date: September 3, 2020
NAD+ Precursor Supplementation With Exercise Training to Increase Aerobic Capacity in Friedreich's Ataxia
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 30
  • Start Date: July 31, 2020
A Phase 1 Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 1000
  • Start Date: July 1, 2020
Biomarker for Friedreich's Ataxia: An International, Multicenter, Observational, Longitudinal Protocol
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: May 20, 2020
A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 225
  • Start Date: March 2020
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 120
  • Start Date: March 1, 2020
Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia : INTREP-AF
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 32
  • Start Date: December 11, 2019
A Phase 1 Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Clinical Trial
Other
  • Status: Not yet recruiting
  • Participants: 450
  • Start Date: November 15, 2019
Retrospective Study of Causes Associated With Small Fiber Neuropathies.
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 60
  • Start Date: October 30, 2019
A Randomized, Double-Blind, Controlled, Phase 2/3 Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
Showing 1–12 of 26 Clinical Trials
Next